15/10/2026
What was my (main!) takeaway?
EASD was heavily focused on , early detection, prevention and lots (and lots) of thoughts and insights on what the role of AI should be/is in diabetes care.
But they weren’t my main takeaway. It was how many conversations considered similar types of questions to “how do we make diabetes care work better for the person living with it?”
Whether it’s the use of technology (or not!), nutritional choices, treatment burden, diabetes distress, shared decision-making, access, equity of care, or implementation. I noticed it within the discussions of various topics.
For me, it boils down to individualising diabetes care around the person, and not (just!) the technology, treatment or guideline.
As we know, the latest technology isn’t automatically the right choice for everyone (there’s no one-size-fits-all in diabetes tech!). And a lower HbA1c doesn’t tell the whole story. Also, an evidence-based intervention only makes a difference if it works in the context of someone’s actual (real!) life.
After 41 years of living with type 1 diabetes, I’ve learned that managing diabetes is about so much more than the numbers. And as a patient advocate, researcher and person-centred care consultant, I strongly believe we need to take a more holistic look at diabetes care. Does this particular intervention improve outcomes that matter to the person? Does it actually reduce the burden of diabetes, or simply redistribute it? And: are we making decisions with people, or for them?
Going from prescribing treatments to understanding people might sound obvious. Yet, putting it into practice requires a fundamental change in how we think about diabetes care.
The goal isn’t just better diabetes management. It’s better decisions, for real people, living real lives.
What would you add?